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Parasitic infections are prevalent in both tropical and subtropical areas. Most of the aﬀected and/or exposed populations are living
in developing countries where control measures are lacking or inadequately applied. Although signiﬁcant progress has been made
in our understanding of the immune response to parasites, no deﬁnitive step has yet been successfully done in terms of operational
vaccines against parasitic diseases. Evidence accumulated during the past few years suggests that the pathology observed during
parasitic infections is in part due to deregulation of normal components of the immune system, mainly cytokines, antibodies, and
immune eﬀector cell populations. A large number of studies that illustrate how parasites can modify the host immune system for
their own beneﬁt have been reported in both metazoan and protozoan parasites. The ﬁrst line of defense against foreign organisms
is barrier tissue such as skin, humoral factors, for instance the complement system and pentraxin, which upon activation of
the complement cascade facilitate pathogen recognition by cells of innate immunity such as macrophages and DC. However,
all the major groups of parasites studied have been shown to contain and/or to release factors, which interfere with both arms
of the host immune system. Even some astonishing observations relate to the production by some parasites of orthologues of
mammalian cytokines. Furthermore, chronic parasitic infections have led to the immunosuppressive environment that correlates
with increased levels of myeloid and T suppressor cells that may limit the success of immunotherapeutic strategies based on
vaccination. This minireview brieﬂy analyzes some of the current data related to the regulatory cells and molecules derived from
parasites that aﬀect cellular function and contribute to the polarization of the immune response of the host. Special attention is
given to some of the data from our laboratory illustrating the role of immunomodulatory factors released by protozoan parasites,
in the induction and perpetuation of chronic disease.
Copyright © 2007 Ali Ouaissi. This is an open access article distributed under the Creative Commons Attribution License, which
permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. INTRODUCTION
There is increasing evidence that immune mechanisms are
involved in the pathogenesis of many parasitic infections.
The initial stages of the disease are generally characterized
bytheinductionofanonspeciﬁclymphoproliferation,which
is believed to disrupt antigen recognition and interfere with
protective immune responses. Paradoxically, in most cases a
state of immunosuppression can be evidenced. This hypore-
sponsiveness to antigen-speciﬁc and polyclonal stimuli in
chronic parasitic infections could be related to immunosup-
pressivecytokines(i.e.,IL-10andTGF-β)secretedbyantigen
presenting cells and regulatory T cells (Treg cells). A growing
list of parasite-derived molecules able to exert immunomod-
ulatory activities on the cells of the innate immunity leading
to such polarized cytokine secretion has been reported [1, 2].
Interestingly, these immunosuppressive regulatory responses
resulting from repeated exposure to pathogens and/or their
released products have been postulated to be responsible for
protection against inﬂammatory diseases such as allergy or
autoimmunity leading to the germless theory of allergic dis-
eases and the hygiene hypothesis [3, 4]. This has led investi-
gators to search for parasite molecules which could be used
as a new therapy for immunological disorders [5].
In fact, complex feedback loops could explain the prop-
erties of a suppressor activity seen in parasitic infections.
For instance, the parasites cannot only induce the pro-
duction of host immunomodulatory lipids, the best char-
acterized being the endogenous eicosanoids, but are also
able to synthesize/secrete their own glycoproteins and lipids,
which in turn activate cells of innate immunity towards the
anti-inﬂammatory cytokine response. This physiological mi-
croenvironment may favor the development of Treg cells. A
number of excellent reviews were devoted to the Treg cells2 Journal of Biomedicine and Biotechnology
and their physiological role at the level of peripheral self-
tolerance, avoidance of autoimmune diseases, tumor, and in-
fectious disease immunology [6–13].
The purpose of this minireview is to analyze some of
the current data related to the regulatory components or
processes originating from the parasite (protozoa and some
helminth pathogens) that aﬀect host cellular functions lead-
ing to an immunosuppressive state that counteract proin-
ﬂammatorycytokineproductionwhichmayleadtoexcessive
host tissue damage. The outcome of a parasitic infection will
depend on the ﬁnal balance of the protective and pathologi-
cal properties of the cytokine network.
2. INDUCTION OF SUPPRESSOR CELLS
Immunosuppression involves an act that reduces the activa-
tion or eﬃcacy of the immune system. Some components
of the immune system itself have immunosuppressive ef-
fects on other parts of the immune system, and immunosup-
pression may occur as an adverse reaction to treatment or
other conditions like infection processes. The ability of par-
asites to survive in the immune hosts depends on a variety
of escape mechanisms. One of these is the inhibition or the
suppression of the immune responses of their hosts. Several
possible explanations have been put forward, such as anti-
genic competition, acquired tolerance, as well as the possible
blockingroleofsolubleantigensorcirculatingimmunecom-
plexes. The release by the parasites themselves of excretory-
secretory products, which have potent immunosuppressive
activity,representsanotherpossibleexplanation.Moreover,a
large number of reports have described the presence of sup-
pressor cells (T lymphocytes and macrophages) in humans
and animals infected with various parasites.
For instance, during onchocerciasis due to a pathogenic
human ﬁlarial worm, Onchocerca volvulus, a state of cellu-
lar immune unresponsiveness develops in patients with the
generalized form of the disease [14]. Moreover, it has been
reported that parasite antigens are present in breast milk of
O. volvulus-infected women which activated cells that sup-
pressed the proliferative response of autologous lymphocytes
to mitogens and antigens, suggesting therefore that this may
induce tolerance and/or suppression in infants born of in-
fected mothers [15].
A number of years ago, we have shown that total antigens
from O. volvulus (OVA) markedly inhibited the proliferation
of normal human lymphocytes stimulated with polyclonal
activators such as phytohaemagglutinin (PHA). The inhibi-
tion was not due to a cytotoxic eﬀect of OVA and was not ab-
rogated by removal of the adherent cell population. Interest-
ingly, we showed that the in vitro response of normal human
lymphocytes was suppressed by coculture with allogeneic or
syngeneic lymphocytes, which had previously been exposed
to OVA. A signiﬁcant reduction of the suppression was how-
ever observed when OVA pretreated cells were depleted of T
cells by centrifugation of E rosettes. Moreover, the passage
of OVA through an immunoadsorbant column containing a
monoclonalantibodytoOVAepitopeabrogateditsimmuno-
suppressiveeﬀect.Theseobservationsallowedustopostulate
thataparasiteantigen(s)wasresponsiblefortheinductionof
T suppressor cells [16]. Since the molecular mechanisms of
suppressor cells were diﬃcult to characterize, interest in such
cells was lost.
Recent progress in the identiﬁcation of CD4+ Tc e l lp o p -
ulations, together with the use of genetically modiﬁed an-
imal models have led to signiﬁcant advances in the under-
standing of the immunosuppression phenomenon at the cel-
lular and molecular levels. The concept of T regulatory cells
(Treg) suppressing immune responses via cell-cell interac-
tions and/or the production of suppressor cytokines are cur-
rently well documented [6–9]. At least two main Treg cell
populations were deﬁned: “naturally” occurring regulatory
Tc e l l s( F o x p 3 + CD4+ CD25+) and the “adaptive” regula-
tory T cells (e.g., TR1o rT H3) [10–12]. Although some con-
troversy has been reported in the literature, evidence which
accumulated over the years has undoubtedly shed light on
the importance of Treg cells in health and disease. Thus, in
the case of onchocerciasis, a series of reports has shown that
the hyporesponsiveness in individuals with the generalized
form of the disease is not due to a shift towards a TH2r e -
sponse. Rather, it results from O. volvulus antigen-speciﬁc T
cells having a cytokine proﬁle with no IL-2 and high IL-10
and TGF-β production similar to the adaptive Treg cells also
known as TR1a n dT H3 which suppress ongoing inﬂamma-
tion [17, 18]. Cloning procedures allowed obtaining T cell
clones bearing TR1 suppressor cytokine proﬁle producing
signiﬁcantamountsofIL-10butnoIL-2orIL-4andexpress-
ing high levels of cytotoxic T lymphocyte antigen (CTLA-4)
after stimulation.
Although the examination of T cell lines or clones de-
rived from the peripheral blood mononuclear cells of in-
fected individuals has the great advantage that the cells pro-
ducing the cytokines can be accurately deﬁned, in this case
the cytokines derived from “neighboring” cells in vivo are no
longer represented in the system. Nevertheless, the genera-
tion of T cell clones has provided valuable information on
human responses in general and to infections in particular.
However, when considering a wide range of autoimmune
and inﬂammatory manifestations, the mechanisms by which
regulatory Treg cells exert their activity remain unclear. For
instance, studies in vivo have demonstrated that regulation
is dependent on cytokines such as IL-10 and TGF-β as well
as the expression of CTLA-4 molecule [19, 20]. However, in
vitro studies have shown that neither soluble cytokines nor
CTLA-4 is required for the suppressive eﬀects of Treg [21–
23]. Moreover, it has been shown that regulation of the ileal
inﬂammatory process resulting from Toxoplasma gondii in
murine model is dependent on TGF-β producing intraep-
ithelial lymphocytes suggesting therefore that these cells rep-
resent an essential component in gut homeostasis after oral
infection with this parasite [24]. Furthermore, in the sus-
ceptible BALB/c mouse experimental model of ﬁlarial in-
fection with Litomosoides sigmodontis,ap a r a s i t ec l o s e l yr e -
lated to Brugia and Wuchereria species causing human lym-
phatic ﬁlariasis, the Treg cells have been shown to be re-
sponsible for susceptibility to parasite. However, although
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glucocorticoid-inducedTNFreceptorfamily-relatedgenere-
duced Treg activity and led to increased antigen-speciﬁc im-
mune responses, this results in the signiﬁcant reduction of
parasite numbers, in vivo neutralization of IL-10 receptor,
but did not restore the ability of the immune system to kill
parasites, supporting the notion that Treg cells act in an IL-
10-independent manner [25].
Nevertheless, a recent study has shown that in a murine
model of coinfection with a gastrointestinal nematode para-
site Heligmosomoides polygyrus and the blood-stage malaria
parasite Plasmodium chabaudi increased levels of IL-10. This
occurred in concurrent infections, whereas high levels of
TGF-β were seen during P. chabaudi single infections [26].
Interestingly, anthelminthic drug treatment of mice before
P. chabaudi infection reduced TGF-β levels and restored an-
timalarial immunity. Thus, induction/expansion of the sup-
pressor function is a complex process depending on multiple
factors,amongwhichconcurrentinfectionsarehighlypreva-
lent in many endemic tropical and subtropical regions of the
world.
Hyporesponsiveness also occurs during human schisto-
somiasis. In fact, the infection downregulates both TH1a n d
TH2cytokines[27].Inmorerecentstudies,ithasbeenshown
that in a mouse schistosomiasis, Treg cells and IL-10 inhib-
ited TH1d e v e l o p m e n t[ 28] and egg-induced pathology [29].
However, a number of studies have pointed to the role of
IL-10 and TGF-β (two cytokines being released by adaptive
Treg cells) as immunomodulatory cytokines in helminth in-
fections. Parasite-speciﬁc activation of natural Treg cells has
been reported in mice Leishmania major infection [30]. The
cells were positive for Foxp3, produce IL-10 in response to
Leishmania-infected dendritic cells, and exerted strong sup-
pressive activity in vitro. In fact, previous observations have
shown that in the case of L. major infection of genetically
resistant C57BL/6 mice which spontaneously heal their der-
mal lesions with persistence of latent parasites, CD4+ Tc e l l s
are the main producers of IFN-γ and IL-10 in the dermis,
although CD8+ T cells were also able to produce either cy-
tokine with appropriate stimuli [31]. Similar to TR1 cells, the
majority of CD4+ T cells in the dermis and a proportion of
CD4+ T cells in the draining lymph nodes were able to pro-
duce both IL-10 and IFN-γ. Thus, in the chronic sites of in-
fection, the release of IL-10 and IFN-γ by T cells led to the
establishment of a latency with persistence of low number of
viable parasites within lymphoid tissue and skin lesion after
self-cure.
Although the T cell network seems to play a key role
in the immunosuppression process, the existence of other
T-cell-independent mechanisms has been clearly demon-
strated. Indeed, recent investigations have shown that
helminth and protozan infections can elicit a myeloid popu-
lation characterized as Gr-1+/CD11b+ cells that substantially
impaired antigen-speciﬁc T cell responses [32–34].
The myeloid suppressor cell-induced immunosuppres-
sion is mediated by nitric oxide production (NO), a mes-
senger known to be involved in diverse signaling pathways
includingsmoothmusclerelaxation,plateletinhibition,neu-
rotransmission, immune regulation, and destruction of mi-
crobes and tumor cells [35]. The participation of NO in the
suppression of T cell activation has been reported in a num-
ber of biological systems (reviewed in [36]). In fact, NO pro-
duction during toxoplasmosis in C57BL/6 mice has two op-
posite eﬀects being protective against Toxoplasma gondii and
downregulating the immune response, suggesting its possi-
ble contribution in the establishment of chronic infections
[37]. In the case of Trypanosoma cruzi,p r e v i o u ss t u d i e sh a v e
shown that IFN-γ and nonoxidative molecules (TNF-α and
NO) could play a role in the control of T. cruzi infection
in mice [36]. Furthermore, a series of experiments supports
the notion that IFN-γ and TNF-α mediated activation of
macrophages which leads to increased production of NO,
and in turn suppresses T cell activation [38]. The involve-
ment of NO in apoptosis of thymocytes and macrophages
has also been documented [39, 40] and NO markedly in-
hibits the induction of IL-2 promoter, which can account
for most of the reduction in IL-2 production, and weakly
increases the activation of IL-4 promoter [41]. This mech-
anism could be involved in the downregulation of IL-2 gene
expressionobservedduringT.cruziinfection[42].Therefore,
it is likely that NO production during the initial phase of
acute infections might participate in the clearance of para-
sites by macrophages, whereas its overproduction during the
late phase of acute infection would account for the immuno-
suppression observed.
Although signiﬁcant advances have being made regard-
ing the Treg subsets, a recent exiting review pointed to the
importance of B cells possessing regulatory functions and
suggested these be called Breg cells (reviewed in [43]). In-
deed, in addition to the pathogenic role of B cells, which
produce autoantibodies that contribute to the development
of autoimmune diseases, the existence of regulatory B cells
capable of inhibiting inﬂammatory responses through the
production of regulatory cytokines IL-10 and TGF-β has
been demonstrated in a number of experimental models of
chronic inﬂammation [43].
In the case of parasitic infections, a number of studies
have reported several alterations in B cell functions. For in-
stance,inthemousemodelofSchistosomamansoniinfection,
splenic B cells have been shown to proliferate in response to
an oligosaccharidic antigen (see also the next section) and
were triggered to secrete high levels of IL-10 [44]. Further-
more, spleen B cells from mice infected with the L3 larval
stage of ﬁlarial nematode Brugia pahangi contributed sub-
stantiallytoIL-10productionthatinturndownregulatedthe
expression of B7 molecules on the B cell surface [45]. This
led to the decrease of their eﬃciency as antigen presenting
cells to CD4+ T cells and restricting their expansion, suggest-
ing therefore that B-cell-derived IL-10 could participate in
theregulationofproinﬂammatoryCD4responsesasinother
v a r i o u sm o d e l so fa u t o i m m u n ed i s e a s e s[ 46].
2.1. Inductionofapoptosisinthehostimmunecells
Another mechanism leading to the homeostasis disorder
in the host is the fact that the invading parasites can re-
lease factors which kill the cells of the immune system by4 Journal of Biomedicine and Biotechnology
activating the cellular death machinery, thus inducing apop-
tosis. Therefore, apoptosis seems to represent a fundamen-
tal feature with particular relevance in the maintenance of
protozoan infections [47]. Indeed, studies in experimental
mouseT.cruziinfectionshaveshownthatapoptosisofTcells
play an important role in the immunossupression that oc-
curs during the acute phase of Chagas’ disease [48]. In a ca-
nine model of acute Chagas myocarditis, Zhang et al. [49]
have reported that programmed cell death (PCD) occurs in
cardiac myocytes, endothelial cells, macrophages, interstitial
dendritic cells, and lymphocytes, suggesting that parasite-
derived factors could be responsible of the apoptosis ob-
served in the immune cells. In the same way, a correlation
between the extent of PCD and the level of suppression of
CD4+ T-cellproliferativeresponseswasobserved[50].More-
over, it has been suggested that the upregulation of Fas and
Fas ligand play an important role in the induction of CD4+ T
cell death. This pathway is able to control and modulate the
immune response against T. cruzi [51].
Parasite-derived substances are believed to be key factors
in the immunossupression phenomena observed by exerting
a proapoptotic activity against some immune cells. Thus, it
has been reported that the T. cruzi-secreted trans-sialidase
(TS) was able to induce apoptosis features in cells of the im-
mune system in vivo [52]. Furthermore, evidences reported
support that TS is a virulence factor responsible for thymic
alterations via apoptosis of “nurse cell complex” [53]. More-
over, the glycoinositolphospholipid (GIPL) from T. cruzi,i n
the presence of IFN-γ, induced murine macrophage apopto-
sis leading to increased parasite release from these cells [54].
Surprisingly, internalization of apoptotic T lymphocytes by
macrophages increased the replication of T. cruzi amastig-
otes inside macrophages [55]. Another additional mecha-
nism that may amplify the immune suppression process is
the fact that apoptotic cells release their TGF-β during their
suicidal act. They ﬂip intracellular phosphatidylserine onto
the outer leaﬂet of their membranes rendering them target
of phagocytic cells signaling the macrophages to release sig-
niﬁcant amounts of TGF-β which in conjunction with IL-10
and PGE-2 may act as a feedback ampliﬁcation loop mediat-
ing immune suppression.
2.2. PD-1asactivesuppressorofTregulatorycells
Programmed death-1 (PD-1) [56] ,am e m b e ro ft h eC D 2 8
family, is an immunoreceptor tyrosine-based inhibitory-
motif- (ITIM-) containing receptor induced on T, B, and
myeloid cells upon activation in vitro [57]. Interaction of
PD-1 ligands (PD-L1 and PD-L2, members of the B7 fam-
ily) with PD-1 may lead to the inhibition of proliferation and
cell division of activated T cells expressing PD-1. Thus, the
absence of PD-1 induced proliferation of eﬀector T cells in
the adenovirus-infected liver and resulted in rapid clearance
of the virus. The blockage of the PD-1 pathway can augment
antiviral immunity [58]. Recent investigations have reported
that PD-1/PD-L systems may play a role during parasitic in-
fections. Indeed, it has been shown that PD-L1 and PD-L2
have distinct roles in regulating host immunity to cutaneous
leishmaniasis [59]. In fact when compared to wilt-type mice
(WT),thePD-L1−/− andPD-L2−/− exhibiteddistinctdisease
outcomes following infection with L. mexicana.
PD-L−/−mice developed resistance, whereas PD-L2−/−
showed exacerbated disease. Although both PD-L1−/− and
PD-L2−/− produced similar levels of IFN-γ as the WT mice,
the development of IL-4 producing cells was reduced in PD-
L1−/− mice suggesting that impairment of TH2r e s p o n s ed u e
to PD-L1 deﬁciency could be related to increased resistance
to L. mexicana infection. Furthermore, in the case of CBA/J
mouse Schisitosoma mansoni chronic infection, the para-
sites can induce increased expression of PD-L2 on splenic
CD11c+/B220− dendritic cells leading to moderate morbid-
ity [60]. Taken together, these observations suggest that PD-
1/PD-L systems may play a role in negative regulation of im-
mune responses during parasitic infections.
2.3. Parasitereleasedmoleculesas
immunoregulatoryfactors
2.3.1. Lipids
A number of reviews pointed to the importance of endoge-
nous as well as parasite-derived lipids as immunoregulatory
factors [2, 62, 63]. It is well known that eicosanoids such
as prostaglandins PGE2, PGD2, and LipoxinA4 can act not
only on antigen-presenting cells through deﬁned or puta-
tive surface receptors and strongly modify their pattern of
cytokine synthesis (IL-1, TNF-α, IL-12, and IL-10), but also
on T cells at the level of IL-2 synthesis, IL-2 receptor ex-
pression, and cellular proliferation [2]. Glycoinositolphos-
pholipids (GIPLs) are some of the major glycoconjugates
present on the cellular surface of Leishmania [63] and dif-
ferent strains of T. cruzi [64]. T. cruzi GIPL blocks T cell re-
sponses induced by diﬀerent polyclonal activators, the sup-
pressive domain being assigned to the ceramide portion of
the molecule. Indeed, puriﬁed GIPLs from T. cruzi inhibit in
vitro CD4+ and CD8+ T cell proliferation induced by bacte-
rial superantigen and anti-TCR;CD3 antibodies. The inhibi-
tion leads to loss of IL-2 responsiveness, with inhibition of
CD25 expression on both CD4+ and CD8+ subsets [65].
Dendritic cells (DCs) are crucial in the initiation of the
immune response and are distinguishable from the other
antigen presenting cells by their highly eﬃcient antigen pre-
sentation. DCs are specialized to acquire and process antigen
in peripheral nonlymphoid sites, and to transport the anti-
gen to the secondary lymphoid organs where the stimulation
of na¨ ıve lymphocytes occurs. During their migration, DCs
enter a process of maturation that determines whether adap-
tive immune response occurs and the nature of that immune
response. Studies with the glycoinositolphospholipid (GIPL)
from T. cruzi have demonstrated that this molecule led to
a downregulation of human DC surface antigens, such as
CD80, CD86, HLA-DR, CD40, and CD57 that are important
for T cell activation [66]. These observations allowed investi-
gators to propose a novel eﬃcient mechanism leading to the
alteration of DC function and maturation that may be used
by T. cruzi to escape the host immune response. However,
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to remember that the GPI anchors express biological activi-
ties similar to those of lipopolysaccharides (LPS). Given the
fact that LPS induces the maturation of dendritic cells, one
would expect that T. cruzi -derived LPS-like substances could
activate rather than inhibit DC maturation [67]. Therefore,
the observations showing DC inhibition await further expla-
nation. In this regard, it is noteworthy that GPI anchors and
GIPLs from T. cruzi are potent activators of the human and
mouse macrophage toll-like receptor 2 (TLR2) [68].
2.3.2. Polysaccharides
A number of saccharides (from oligosaccharides to complex
polysaccharides) derived from parasites have been identiﬁed
and were shown to be implicated in host cell signaling sys-
tems. Complex polysaccharides for example which are not
digested by the macrophage lysosomal enzymes can be re-
tained intracellularly for a long period of time, interfering
therefore with the presentation of peptide antigens to T cells
[69]. Moreover, these molecules can act directly on the cell
of the immune system. For instance, lacto-N-fucopentaose
III (LNFP-III) and lacto-N-neotetraose (LNnT), sugars of
egg antigens of S. mansoni, also found in human milk were
shown to participate in the TH2 polarization and immune
suppression. Indeed, intraperitoneal injection of LNnT-Dex
intomiceexpandedacellpopulation,phenotypicallydeﬁned
as Gr1+/CD11b+/F4/80+ producing high levels of IL-10 and
TGF-β ex vivo [32].
Gr1+ cells suppressed na¨ ıve CD4+ Tc e l lp r o l i f e r a t i o n
in vitro in response to anti-CD3/CD28 antibody stimula-
tion.Suppressioninvolvedcellcontactandwasdependenton
IFN-γ and NO, with a discrete role played by IL-10 [32]. Fur-
thermore, LNFP-III stimulated splenic B cells from parasite-
infected mice to proliferate and produce IL-10 and PGE2,
two molecules known to downregulate TH1 cells [44]. The
majorsourceofIL-10wastheB-1subset(CD5+ B220+)[70].
Oligosaccharide structures from other parasites have
been shown to modulate B cell activity. Indeed, the T. cruzi
GIPL was found to be a stimulatory factor for B cells, induc-
ing the production of IgG3 in the absence of any costimuli,
the active portion being present in the oligosaccharide frac-
tion [71].
In the case of Leishmania parasites, the major cell sur-
facemolecule,phosphoglycan(PG),hasbeenshowntoselec-
tively inhibit the synthesis of IL-12 (p. 40, p. 70) by activated
murine macrophages. The inhibition was dependent on the
galactose (beta1-4) mannose (alpha1)-PO4 repeating units
and not the GPI lipid anchor of lipophosphoglycan [72].
2.3.3. Polypeptides
In addition to lipids and polysaccharides, parasite-derived
proteins and even small RNA molecules could interfere with
the cell of the immune system. Thus, the glutathione-S-
transferases (GSTs), which are ubiquitous housekeeping en-
zymes found in nearly all animals and some parasites, ap-
peared to have immunomodulatory functions [73]. Indeed,
the dimeric form of GST present in the excretory-secretory
products of Fasciola hepatica exerted a signiﬁcant inhibi-
tion of rat T cell proliferation in vitro and a downregula-
tion of NO production by normal peritoneal macrophages.
Furthermore, in O. volvulus, a novel type of GST possess-
ing the characteristic of secreted protein has been identiﬁed.
In fact, the parasite has two GSTs (ovGST1 and ovGST2),
the ovGST2 functions as an intracellular cytosolic house-
keeping enzyme, whereas the ovGST1 is found in the media
surrounding adult worms maintained in culture, suggesting
therefore that the enzyme is released from the parasite. Re-
cent investigations have shown that O. volvulus extracellular
GST produces PGD2, a known anti-inﬂammatory molecule
[74].
In accordance with these ﬁndings, we have also demon-
strated the ability of a T. cruzi released protein, Tc52, con-
taining a tandemly repeated structure characteristic of glu-
tathione S-transferases (GSTs) to induce nonspeciﬁc sup-
pression of T lymphocyte activation [75]. Furthermore, our
studies have provided evidence demonstrating that puri-
ﬁed Tc52 acted directly on macrophages to increase IL-10
gene expression [76]. In addition, experiments carried out
with murine macrophages harboring a eukaryotic plasmid
carrying Tc52 gene showed increased IL-10 mRNA levels
[77]. Moreover, using synthetic peptides spanning the amino
terminal or carboxy-terminal domain of Tc52 protein, we
found that the sequence encapsing the carboxy-terminal
residues 432–445 when coupled to a carrier protein, ovalbu-
min, exhibited increased inhibitory activity on T lymphocyte
activation and signiﬁcantly downregulated IFN-γ and IL-2
secretions [78].
The in vivo immunomodulatory eﬀect of Tc52 has been
investigated in mice. Given that we have already estab-
lished by genetic manipulation T. cruzi clones lacking a Tc52
protein-encoding allele (Tc52+/−)[ 79], we decided to exam-
ine the disease phenotype in Tc52+/−-infected BALB/c mice,
during the acute and chronic phases of the disease. The re-
sults obtained are in agreement with the observations made
whenusinginvitroexperimentalmodels.Indeed,thesestud-
ies showed a reversion of the suppressive phenotype in vivo
during the infection with mutant parasites lacking one Tc52
gene allele. Moreover, a lack of increased secretion of IL-
10 correlates with decreased in vivo Tc52 production [80].
Therefore, it is reasonable to suggest that this reduction by
genetargetingwhichinturndownregulatestheIL-10synthe-
sis could be among the immunregulatory mechanisms oper-
atingduringT.cruziinfection.Itistemptingtospeculatethat
Tc52-inducingincreasedIL-10secretionmightparticipatein
the downregulation of IL-2 production. This is in agreement
with previous studies showing that murine IL-10 can down-
regulate the host immune response by decreasing the pro-
ductionofIL-2andinhibitingmitogen-drivenTcellprolifer-
ation [81, 82]. Furthermore, the eﬀect of Tc52 on the allergic
airway inﬂammation induced by OVA in the BALB/c strain
of mouse was evaluated. While the OVA challenge induced
increased cellular inﬁltrates in the bronchoalveolar lavage
ﬂuid, simultaneous injection of Tc52 with OVA signiﬁcantly
reduced inﬂammation (Lamkhioued, personal communica-
tion).6 Journal of Biomedicine and Biotechnology
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Figure 1: A model for parasite-derived factors-host cell interaction and signaling pathways.
In view of the fact that increased NO production by
splenic macrophages has been involved in the suppression of
lymphocytes proliferation in mice infected with T.cruzi [38],
we have investigated whether Tc52 modiﬁed macrophage
NO production. We ﬁrst showed that Tc52 could be bound
to the macrophage surface as evidenced by FACS analy-
sis. Moreover, while Tc52 alone had no eﬀect, addition of
IFN-γ induced the production of high amounts of NO by
macrophages correlating with increased levels of iNOS tran-
scripts [76]. It is known that IFN-γ by itself is a relatively
poor stimulator of NO production by macrophages and
the addition of a second signal can signiﬁcantly enhance
NO production [83]. Since high levels of IFN-γ have been
recorded during acute phase mouse T.cruzi infection, and
that Tc52 could be detected in the blood of infected mice,
it is reasonable to suggest that Tc52 may act as a “secondary
signal” for NO secretion by macrophages in vivo, which in
turn could modulate T cell function. This kind of mecha-
nism also occurred in T. brucei infection. Indeed, it has been
reported that NO-mediated suppression of T cells during T.
brucei infection could result from a synergistic eﬀect of sol-
uble trypanosome products and IFN-γ on iNOS expression
[84].
Modulation of iNOS gene and NO production by solu-
ble proteins has also been reported in the case of Entamoeba
histolytica [85].
Although Tc52 could induce the secretion of the sup-
pressive cytokine IL-10 by macrophages, recent investiga-
tions have shown that the protein could trigger human and
mouse DC maturation as evidenced by an upregulation of
costimulatory surface antigens such as CD54, CD86, and
HLA-DR molecules. Moreover, incubation of DC with Tc52
led to increased inﬂammatory chemokine synthesis (IL-
8, monocyte chemoattractant protein-1, and macrophage-
inﬂammatory protein-1α). Interestingly, binding experi-
mentsshowedcomplexmolecularTc52-DCinteractionsthat
involved toll-like receptor 2 and Tc52 glutathione-binding
site which mediated intracellular signaling, whereas another
unidentiﬁed portion of the Tc52 molecule is involved in its
bindingtoDC[86].Infact,theTc52ismadeoftwohomolo-
gous domains comprising a glutathione binding site (G-site)
andahydrophobicC-terminalregion(H-site).Themolecule
may act as a dimeric-like complex where the two “pseudo-
subunits” areas are arranged in an antiparallel fashion sep-
arated by a strong β-turn motif (Ala225-Pro-Gly-Tyr228).
The Tc52 G-site binds to TLR2, the other portion of the
molecule, likely the H-site, interacts with a putative DC sur-
face structure. Binding to the TLR2 activates the signaling
cascade leading to NF-κB nuclear translocation and regula-
tion of nuclear gene expression. It might be that the H-site
interacts ﬁrst with the still unknown DC surface structure,
the membrane-bound receptor-Tc52 complex, then moves
to reach the TLR2 and binds to it through the Tc52 G-site
resulting in the activation of intracellular signaling cascades
leadingtoNF-κBnucleartranslocationandregulationofDC
gene expression.
On ﬁrst examination, the fact that Tc52 activity resulted
in the induction of gene encoding both anti-inﬂammatoryAli Ouaissi 7
(IL-10)andproinﬂammatory(IL-6,IL-8)mediatorsmayap-
pear paradoxical. Yet, in common with other physiological
systems, it is apparent that a counter-regulatory mechanism
isessentialtoprovidethebalanceandregulationthatarenec-
essary to control the inﬂammation cascade. Within the site
of an inﬂammation reaction, IL-10 produced locally would
act to counter the stimulatory eﬀects of IL-8 and IL-6, and
thereby enable the balance to be established.
Other parasite-derived molecules which subvert im-
mune regulation have been described: the T. cruzi antigen
molecule SAPA (shed acute phase antigen) which exhib-
ited a neuraminidase-transsialidase activity downregulated
T lymphocyte proliferation as a consequence of T suppres-
sor/cytotoxic cell activation and secretion of PGE2 [87]. A T.
cruzi membrane glycoprotein inhibited the expression of IL-
2 receptor chains and secretion of cytokines by subpopula-
tions of activated human T lymphocytes [88] among others.
Moreover, parasite-derived polypeptides could act di-
rectly on B cells either as speciﬁc or nonspeciﬁc activators.
Indeed, we have shown that in vivo treatment of mice with a
ﬂagellar Ca+-binding protein, Tc24 from T. cruzi, induced a
quick increase in the number of B cell secreted immunoglob-
ulins of IgM isotype, suggestive of a mitogenic activity of
Tc24 on B cells that is T cell independent [89]. Moreover, we
have identiﬁed an L. major gene encoding a protein sharing
signiﬁcant homology to mammalian ribosomal protein S3a
named LmS3a exhibiting dual activity being stimulatory and
inhibitorytowardsTandBcells,respectively[90].Analysisof
cytokineproductionrevealedasigniﬁcantdownregulationof
IFN-γ, IL-2, and IL-12 secretion by LmS3a. These results are
compatible with mitogenic induction of the immune system
accompanied by a state of immunosuppression.
Another intriguing aspect in the parasite relationship is
the fact that parasites could release factors that mimic host
cytokines. For instance, (1) hydatid ﬂuid fractions mimicked
IL-1, IL-2, and IL-6 [91]; (2) an IFN-γ homolog that binds
to the IFN-γ receptor and induced change in lymphoid cells
has been identiﬁed in an intestinal nematode [92]; (3) two
homologs of the human macrophage migration inhibitory
factor (MIF) have been characterized in the human para-
sitic nematode Brugia malayi a n dt e r m e dB m - M I F - 1a n d
Bm-MIF-2, both having functional properties similar to the
MIF human counterpart [93]; (4) Toxoplasma gondii releases
cyclophilin-18(C-18)thatsignalsthroughthechemokinere-
ceptor CCR5 leading to the IL-12 synthesis by dendritic cells
and a strong protective response [94]; (5) the tapeworm Hy-
menolepis diminuta has been shown to express an IL-12-like
peptide, one of the suggested hypothesis being that the pep-
tide could act as a competitive antagonist for the IL-12 re-
ceptor, thus contributing to the general immunosuppression
[95].
Taken together, these examples raise the distinct possibil-
ity that the production of parasite factors that interact with
cell surface receptors may be one mechanism whereby the
parasite is able to interfere with the regulation of the induc-
tion/initiation phase of the host immune response that may
protect the host from excessive inﬂammation and may po-
tentiate the parasite’s own survival.
2.4. Concludingremarks
The soluble parasite factors can elicit a complex series of
cellular interactions leading to an immunosuppression state
(Figure 1). The fact that immunoregulatory parasite-derived
substances may have additional roles in driving early im-
munological events towards TH2-type or anti-inﬂammatory
responses has opened new areas of investigation looking for
molecules that may represent novel potential therapeutic
agents for the treatment of TH1-mediated inﬂammatory and
autoimmune diseases.
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